Zobrazeno 1 - 10
of 1 761
pro vyhledávání: '"Progestogens"'
Autor:
V. E. Radzinskiy
Publikováno v:
Безопасность и риск фармакотерапии, Vol 12, Iss 3, Pp 247-252 (2024)
The article discusses the issues of polypharmacy and unjustified prescribing in pregnant women. The author— Honoured Scientist of the Russian Federation, Corresponding Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Full Prof
Externí odkaz:
https://doaj.org/article/79215e779d01451ba00f7b80c69a7e8e
Publikováno v:
Безопасность и риск фармакотерапии, Vol 12, Iss 2, Pp 214-229 (2024)
INTRODUCTION. Polycystic ovary syndrome (PCOS) is the main cause of female infertility. Clinical practice guidelines on PCOS recommend combined oral contraceptives (COCs) as first-line therapy. Given the association of PCOS with a number of clinical
Externí odkaz:
https://doaj.org/article/3e5d17f9333247a4ad8fc17993523b47
Autor:
Alina E. Solopova, Patimat M. Alieva, Madina R. Dumanovskaya, Guzal I. Tabeeva, Iuliia A. Ivannikova, Antonina A. Smetnik, Stanislav V. Pavlovich
Publikováno v:
Гинекология, Vol 26, Iss 2, Pp 135-140 (2024)
Endometriosis affects about 10% of women of reproductive age and can negatively impact their quality of life (QoL). Due to the heterogeneity of symptoms or even their absence, early diagnosis is difficult. Therefore, it is necessary to comprehensivel
Externí odkaz:
https://doaj.org/article/3c3708c7ff8d455288be4ded008c71c2
Autor:
A.V. Boichuk, D.G. Herman, Y.O. Dubossarska, N.F. Zakharenko, L.V. Kalugina, N.V. Kosei, S.I. Reheda, N.M. Rozhkovska, T.F. Tatarchuk, O.V. Trokhymovich, O.G. Yashina, N.V. Yarotska
Publikováno v:
Репродуктивная эндокринология, Iss 70, Pp 8-14 (2023)
Endometriosis affects 10% of all women of reproductive age, i.e. 190 million patients. Ukraine currently does not gather statistics on the incidence of endometriosis, but, at a rough estimate, this number is approximately 280 thousand women and the r
Externí odkaz:
https://doaj.org/article/d987d4712124451bbb9513ce73dcabdb
Publikováno v:
Репродуктивная эндокринология, Iss 68, Pp 22-28 (2023)
Miscarriage remains an important global problem: 23 million miscarriages are registered annually in the world, i.e. 44 pregnancy losses every minute, and the total risk of miscarriage is 15.3% of all pregnancies. Effective methods of pregnancy preser
Externí odkaz:
https://doaj.org/article/c654fcebc9944798a83eb4e97aaa1770
Combined oral contraceptives: update recommendations of the Latin American contraceptive association
Autor:
Santiago Palacios, Gabriela Ayala, Gemarilis González, Can L. Badilla-Apuy, Jeannette Marchena, Katia Martínez, Desireé Mostajo, María S. Vernaza, Alejandro Paradas, Luis Hernández, David Vásquez-Awad, Cuauhtémoc Celis-González, Nilson Roberto de Melo
Publikováno v:
Gynecological Endocrinology, Vol 39, Iss 1 (2023)
Background: In recent years, new combined oral contraceptives (COCs) have become available, representing an advance in terms of individualization and compliance by users.Objective: To provide recommendations regarding COCs: formulations, use, efficac
Externí odkaz:
https://doaj.org/article/0b4ef3091f184d20aa0c1b41edf03296
Autor:
Marie-Odile Soyer-Gobillard, Laura Gaspari, Françoise Paris, Philippe Courtet, Charles Sultan
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 16 (2023)
Since the middle of the 20th century, synthetic sex hormones (estrogens and progestins) have been administered to millions of pregnant or not women worldwide, mainly to avoid miscarriage or for comfort, although their mode of action and their effects
Externí odkaz:
https://doaj.org/article/b1d555d2f6aa46deae77633ef5f04f3d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xiangyan Ruan, Alfred O. Mueck
Publikováno v:
Global Health Journal, Vol 6, Iss 2, Pp 61-69 (2022)
Menopausal hormone therapy (MHT) is used to treat menopausal complaints including the genitourinary syndrome of menopause, to prevent osteoporosis, and to treat bleeding problems. Since these can be the indications also in young women, especially wit
Externí odkaz:
https://doaj.org/article/7b31f81003bb4e8a94f495a41c5b0e92
Autor:
Yu Deng, Hongyan Jin
Publikováno v:
Cancer Biology & Medicine, Vol 19, Iss 4, Pp 432-449 (2022)
Menopausal hormone therapy (MHT) has been widely used for the clinical treatment of symptoms associated with menopause in women. However, the exact nature of the relationship between MHT and the increased risk of breast cancer has not been fully eluc
Externí odkaz:
https://doaj.org/article/3553df827a374fa584f3325b7f574be4